Berlex wins Ultravist supply contract:
This article was originally published in Clinica
Berlex Laboratories has been awarded a four-year supply contract with New York Medical Imaging for its Ultravist (iopromide) injectable X-ray contrast agent. The agreement is worth some $6 million over the full period of the agreement. Montville, New Jersey-based Berlex is the US affiliate of German company Schering.